Already funded by the Kuni Foundation This project takes preclinical testing that might last 10 weeks at a cost of $45,000 down to 12 days

Already funded by an anonymous donor The goal of this project is to optimize a selective TrkB inhibitor for ligand-dependent neuroblastoma.

Already funded by CureMEC and an anonymous donor The goals of this multi-year research program aim to answer the fundamental questions about Myoepithelial Carcinoma (MEC)

Already funded by the Megan’s Mission Foundation Rhabdomyosarcoma and soft tissue sarcomas are among the five greatest causes of death from childhood cancer and are

Already funded by the Megan’s Mission Foundation Childhood muscle cancer is rare but also unique among cancers – rhabdomyosarcoma not only mimics normal muscle stem

Already funded by the Rucker Collier Foundation! Sclerosing Epithelioid Fibrosarcoma (SEF) is a rare soft tissue sarcoma of children, teenagers and adults that can also

Already funded by the National Cancer Institute/National Institutes of Health! Alveolar rhabdomyosarcoma (aRMS) is generally not survivable when metastatic.  However, this disease does respond to

Already funded by the Macy Easom Cancer Research Foundation The Macy Easom Research Foundation and cc-TDI have been longstanding partners with a series of milestones:

Already funded by Golf Fights Cancer Ewing sarcoma can be a very treatable and curable condition of children, teenagers and adults except in instances that

Already funded by the Lekofsky Family Foundation! An unmet clinical need exists for children with Wilms’ tumor that present with anaplastic (unfavorable) histology. While traditional